We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The Nigerian-born composer Akin Euba (1935–2020) saw it as his life’s mission to create an ‘African art music’: ‘a form of music [that is] universal to all Africa’. As the chapter will outline, his career took him from Lagos to Bayreuth (Germany) and, eventually, Pittsburgh (USA), in the course of which he came up with the notions of ‘African pianism’, ‘creative ethnomusicology’ and, finally, ‘intercultural composition’, of which he was an acknowledged pioneer. Rather than seeing intercultural composition as a contradiction of African art music, I argue that Euba’s music embodies the concept of cosmopolitanism as a series of concentric circles as proposed by the Stoics, whereby the local (Yoruba) is contained in a wider (pan-African) sphere, which is in turn encapsulated in the universal. Compositionally, this vision is realised through the combination of elements from Yoruba music, such as timelines, other African influences from the likes of xylophone and mbira music and Western modernism, exemplified by serialism. As my analyses show, these elements are integrated to such an extent as to become inextricable.
The central argument of this chapter is that the poetry produced from 1965 to 1995 becomes legible as forming an Asian American poetics only about a decade after the period’s closing date. The chapter focuses on identifying and unpacking two foundational interpretive frameworks characterizing recent discussions of Asian American poetry. The first theorizes a crucial temporal discontinuity within the timeline of that poetry, beginning in the early 1980s with the publication of Theresa Hak Kyung Cha’s Dictee (1982). The second theorizes how contemporary Asian American poetics deploys this central discontinuity as a strategic necessity that allows a more flexible consideration of how Asian American poetry develops in parallel with the broader goals of the Asian American political movement, grounded in the late 1960s. Utilizing these two foundational frameworks, critical formulations of an Asian American poetics enact a subtle but significant transition away from discussions of the politics of race and representation, and toward a broader theoretical mapping of the politics of race as form, while nonetheless remaining committed to the sociopolitical project of Asian American studies.
The Pharmaceutical Benefits Scheme (PBS) provides timely, reliable, and affordable access to necessary medicines for Australians. We reviewed the Pharmaceutical Benefits Advisory Committee (PBAC) submissions and their related outcomes and timelines since 2010.
Methods
We examined the PBS Website to identify submissions and their related PBAC outcomes for new medicines, new indications, and new combination products that had been considered by the PBAC since 2010.
Results
Thirty-five PBAC meetings were held during the study period, at which the Committee considered 781 submissions (1,074 medicine/patient population pairings). We saw an increase in the annual number of submissions (medicine/patient population parings). The recommendation rate for the study period was higher than the rejection rate. The annual mean value for the period from the date of initial PBAC recommendation to the date of PBS listing ranged from 357 to 644 days; the annual mean value for the period of the date of PBAC recommendation to the date of PBS listing ranged from 187 to 245 days. It took, on average, 1.70 submissions that included an economic evaluation to obtain a PBAC recommendation. It took more submissions to obtain a PBAC recommendation for a cost-effectiveness analysis submission than it did for a CMA submission. The PBAC was willing to recommend medicines for most acceptable base-case incremental cost-effectiveness ratio (ICER) bands, and the majority of the PBAC did not recommended any medicine in the study period that had a base-case ICER >AUD75,000.
Conclusions
The results of our analyses reveal a minor reduction in the period from the date of PBAC recommendation to the date of PBS listing. Several analyses were hampered by a high proportion of missing data.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.